RemediumOne has conducted three phase III oncology clinical trials recruiting 70+ study participants.
March 28, 2020
Metastatic HER2-Overexpressing Breast Cancer
RemediumOne has partnered with global Sponsor and CRO to conduct this project in Sri Lanka at National Cancer Institute. Within 16 weeks both ERC and Regulatory approvals were obtained. Sri Lanka has achieved 100 % […]READ MORE
January 15, 2020
Dukes C or high-risk Dukes B colorectal cancer
High quality evidence indicates that aspirin is effective in reducing colorectal polyps; and numerous epidemiological studies point towards an ability to prevent colorectal cancer. However, the role of Aspirin as an adjuvant agent in patients […]READ MORE